Image de couverture de livre

Bayesian Adaptive Enrichment Design for Continuous Biomarkers

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yue Tu, Yusha Liu, Wendy J. Mack, Lindsay A. Renfro
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Statistics in Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Bayesian Response Adaptive Randomization for Randomized Clinical Trials With Continuous Outcomes: The Role of Covariate Adjustment
par: Vahan Aslanyan, et autres
Publié: (2024)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
par: Alessandra Serra, et autres
Publié: (2025)

BEAM: Bayesian Hybrid Design With Adaptive Sample Size Through Multisource Exchangeability Modeling
par: Feng Tian, et autres
Publié: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
par: Yunyi Liu, et autres
Publié: (2026)

A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine
par: Yuan Li, et autres
Publié: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
par: Yingjie Qiu, et autres
Publié: (2026)

Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies
par: Dadong Zhang, et autres
Publié: (2024)

Exploring Sensitive Biomarkers Associated With Short‐Term Responses and Long‐Term Outcomes Using Bayesian Additive Regression Trees
par: Zixuan Yao, et autres
Publié: (2026)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
par: Gi‐Ming Wang, et autres
Publié: (2026)

DOD ‐ SSR : An Adaptive Seamless Phase II / III Design With Dose Optimization Decision and Sample Size Re‐estimation
par: Meizi Liu, et autres
Publié: (2025)

Adaptive Designs in Trials With Time‐to‐Event Endpoints and Covariate Adjustment
par: Daniel Backenroth, et autres
Publié: (2026)

Transformed ROC Curve for Biomarker Evaluation
par: Jianping Yang, et autres
Publié: (2024)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
par: Moka Komaki, et autres
Publié: (2026)

Combining Biomarkers to Improve Diagnostic Accuracy in Detecting Diseases With Group‐Tested Data
par: Jin Yang, et autres
Publié: (2024)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
par: David S. Robertson, et autres
Publié: (2025)

A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design
par: Cyrus Mehta, et autres
Publié: (2025)

COMIC: A Bayesian Dose Optimization Design for Drug Combination in Multiple Indications With Application to CAR‐T Therapies
par: Kai Chen, et autres
Publié: (2025)

BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes
par: Cheng‐Han Yang, et autres
Publié: (2026)

Approximate balancing weights for clustered observational study designs
par: Eli Ben‐Michael, et autres
Publié: (2024)

Optimal Linear Combination of Biomarkers by Weighted Youden Index Maximization
par: Sizhe Wang, et autres
Publié: (2025)

Semiparametric Modeling of Biomarker Trajectory and Variability With Correlated Measurement Errors
par: Renwen Luo, et autres
Publié: (2025)

Bayesian Network Meta‐Analysis With One or Two Continuous Outcomes Measured at Multiple Time Points Using Gaussian Random Walks With Drift
par: Pai‐Shan Cheng, et autres
Publié: (2026)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
par: Ryota Ishii, et autres
Publié: (2025)

A Note on “A Comparison of Two Methods for Adaptive Multi‐Arm Two‐Stage Design”
par: Silke Jörgens, et autres
Publié: (2026)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
par: Xinran Huang, et autres
Publié: (2024)

Improved Centile Estimation by Transformation And/Or Adaptive Smoothing of the Explanatory Variable
par: R. A. Rigby, et autres
Publié: (2026)

A Bayesian Causal Model for Matrix‐Valued Exposures With Applications to Radiotherapy Planning
par: Zijin Liu, et autres
Publié: (2026)

Bayesian Sensitivity Analysis for Causal Estimation With Time‐Varying Unmeasured Confounding
par: Yushu Zou, et autres
Publié: (2026)

Dir‐GLM: A Bayesian GLM With Data‐Driven Reference Distribution
par: Entejar Alam, et autres
Publié: (2025)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
par: Marianthie Wank, et autres
Publié: (2024)

A Bayesian Approach to the G‐Formula via Iterative Conditional Regression
par: Ruyi Liu, et autres
Publié: (2025)

Bayesian survival analysis with INLA
par: Danilo Alvares, et autres
Publié: (2024)

Regression Adjustment in Covariate‐Adaptive Randomized Experiments With Missing Covariates
par: Wanjia Fu, et autres
Publié: (2025)

Time‐Dependent ROC Curve for Multiple Longitudinal Biomarkers and Its Application in Diagnosing Cardiovascular Events
par: Lizhe Sun, et autres
Publié: (2025)

A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods
par: Lori P. Selby, et autres
Publié: (2025)

Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling
par: David Svensson, et autres
Publié: (2026)

A Generalized Bayesian Stochastic Block Model for Microbiome Community Detection
par: Kevin C. Lutz, et autres
Publié: (2025)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
par: Jingyan Fu, et autres
Publié: (2025)

Identifying Less Burdensome and More Cost‐Efficient Incomplete Stepped Wedge Designs for Continuous Outcomes Collected via Repeated Cross‐Sections
par: Ehsan Rezaei‐Darzi, et autres
Publié: (2025)

Adaptive Sparsening and Smoothing of the Treatment Model for Longitudinal Causal Inference Using Outcome‐Adaptive LASSO and Marginal Fused LASSO
par: Mireille E. Schnitzer, et autres
Publié: (2026)